Navigation Links
Alexza Reports 2011 First Quarter Financial Results and Provides Business Update
Date:5/9/2011

he centralized registration procedure with the European Medicines Agency (EMA) and was also notified of the Rapporteur and co-Rapporteur appointments for the AZ-004 review.  The Company has confirmed a filing target date with the EMA and plans to submit the MAA late in the third quarter of 2011.


  • On May 6, 2011, the Company issued an aggregate of 11,927,034 shares of its common stock and warrants to purchase up to an additional 4,174,457 shares of its common stock in a registered direct offering.  Net proceeds from the offering were approximately $15.8 million, after deducting estimated offering expenses.  The warrants will be exercisable six months after issuance at $1.755 per share and will expire five years from the date of issuance. The shares of common stock and warrants are immediately separable and will be issued separately.  The securities were sold pursuant to a shelf registration statement declared effective by the SEC on May 20, 2010.   Alexza believes that, based on its cash, cash equivalents and marketable securities balance at March 31, 2011, the net proceeds from the May financing, and the Company's expected cash usage, it has sufficient capital resources to meet its anticipated cash needs into the first quarter of 2012.  Changing circumstances may cause Alexza to consume capital significantly faster or slower than currently anticipated, or to alter its operations.  Financial Results - Periods Ended March 31, 2011 and 2010

    Alexza recorded $1.3 million of revenues in the quarter ended March 31, 2011, and no revenues in the quarter ended March 31, 2010.  The 2011 revenues are a result payments received under the license agreement with Cypress Biosciences, Inc.

    Operating expenses were $9.1 million and $12.6 million in the quarters ended March 31, 2011 and 2010, respectively.  Research and development expenses were $6.3 million and $7.6 million in the quarters end
    '/>"/>


  • SOURCE Alexza Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Alexza to Present at the MDB Bright Lights Conference 2011
    2. Alexza Prices $16.1 Million Registered Direct Offering
    3. Alexza Reports 2010 Fourth Quarter and Full Year Financial Results and Provides General Corporate Update
    4. Alexza to Announce 2010 Year-End Financial Results on Tuesday, March 15, 2011
    5. Alexza Pharmaceuticals Completes End-of-Review Meeting With FDA for AZ-004 (Staccato® Loxapine) NDA
    6. Alexza Pharmaceuticals Provides Regulatory Update for AZ-004 (Staccato® Loxapine)
    7. Alexza Pharmaceuticals Reports 2010 Third Quarter Financial Results and Provides Business Update
    8. Alexza Pharmaceuticals to Announce 2010 Third Quarter Financial Results on November 9, 2010
    9. Alexza Pharmaceuticals Reacquires U.S. and Canadian Rights for AZ-004 (Staccato® Loxapine)
    10. Valeant Pharmaceuticals Announces That Alexza Pharmaceuticals Has Received a Complete Response Letter for AZ-004 (Staccato® Loxapine) Inhalation Aerosol NDA
    11. Alexza Pharmaceuticals Receives Complete Response Letter for AZ-004 (Staccato® Loxapine) NDA
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/23/2014)... Sept. 23, 2014   MedNet Solutions , a global ... is pleased to announce that it will once again be ... (SCDM) Annual Conference, to be held this year from September ... , Nevada. MedNet team members, in conjunction with representatives from many ... will also be in attendance, will be providing demonstrations of ...
    (Date:9/23/2014)... ORLANDO, Fla. and DUBLIN ... Inc. (OTC-BB: TNIB) ("we" or the "Company"), a ... innovative therapies for autoimmune diseases in emerging nations, ... has approved our common stock for DTC,s Deposit ... Fast Automated Securities Transfer Service ("FAST") transfer agent ...
    (Date:9/23/2014)... Sept. 23, 2014  Hill-Rom (NYSE: HRC ... Health ( Renton, WA ), the nation,s ... the companies, existing relationship as Hill-Rom now becomes Providence ... capital bed frame and surface products. ... in the U.S.  It operates 34 hospitals, 475 physician ...
    Breaking Medicine Technology:MedNet Solutions - Proud To Sponsor The SCDM 2014 Annual Conference 2TNI BioTech, Inc. Announces Its Stock is Now DTC DWAC/FAST Eligible 2TNI BioTech, Inc. Announces Its Stock is Now DTC DWAC/FAST Eligible 3TNI BioTech, Inc. Announces Its Stock is Now DTC DWAC/FAST Eligible 4Hill-Rom Announces Seven-Year, Sole-Source Contract with Providence Health 2
    ... SILVER SPRING, Md., May 2, 2011 The U.S. ... used with diet and exercise, to improve blood glucose ... (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) People with Type ... insulin, a hormone that regulates the amount of glucose ...
    ... and SEATTLE, May 2, 2011 CMC Biologics, ... in Copenhagen, Denmark and Seattle, Washington USA, announced ... serve at its Chief Executive Officer. CMC Biologics, ... delivering  world class, fully integrated, biopharmaceutical process development ...
    Cached Medicine Technology:FDA Approves New Treatment for Type 2 Diabetes 2CMC Biologics Announces Appointment of New CEO 2
    (Date:9/23/2014)... 23, 2014 Dr. Connie Casad has announced ... to new office space at 12200 Park Central Drive, Suite ... office will be Park Cities Aesthetics, Optimal Health and Wellness, ... announcing her move, Dr. Casad said, “The patients’ comfort and ... select, we want them to always feel like their needs ...
    (Date:9/23/2014)... (HealthDay News) -- A test used to diagnose lung cancer ... lung infections are more common, a new analysis says. ... the use of what,s known as functional imaging. For lung ... used, according to the study authors. Cancerous tumors generally ... of the lungs that don,t have cancer, according to background ...
    (Date:9/23/2014)... Avid collector Andrew Hawley, from Vintage Rock Posters, announces ... concert posters. The Doors were a smash hit after the ... Seattle Eagles Auditorium concert was held on July 23. ... Auditorium in November the same year. The artist that created ... three colors. The poster is a split fountain silkscreen printed ...
    (Date:9/23/2014)... September 23, 2014 What: Rutgers ... Upper West Side that embodies the inclusion and ... Christians, Scripture and the Ecological Crisis, a public ... Rhodes Professor Emerita of Old Testament at Louisville ... ancient wisdom that lends insight into current ecological ...
    (Date:9/23/2014)... CORVALLIS, Ore. A recent Oregon survey about an ... into the daily routine of elementary school students found ... students and teachers, and offered clear advantages for overly ... was developed and produced by the Healthy Youth Program ... and is available nationally. , Brain Breaks leads children ...
    Breaking Medicine News(10 mins):Health News:Dr. Connie Casad Moving to New Office Location 2Health News:Lung Infections May Hamper Ability to Detect Lung Cancer 2Health News:Inhabiting Eden: Christians, Scripture, and the Ecological Crisis – Public Lecture to Discuss Faith-Based Environmentalism 2Health News:'Brain Breaks' increase activity, educational performance in elementary schools 2Health News:'Brain Breaks' increase activity, educational performance in elementary schools 3
    ... is sheer torture for your aching back too. If ... bring relief. ,Inserting fine needles into the ... pain and even moderately severe depression. ,"Acupuncture ... such as migraines and arthrosis, but also stress and ...
    ... Minister Pranab Mukherjee who is undergoing treatment for head injuries ... discharged// on tomorrow. The minister met with a road accident ... to the doctors attending him. ,A team of ... found him "active and cheerful". ,"He is ...
    ... thought that hypoglycemic coma causes brain damage. On the contrary ... the coma//, as discovered by researchers from San Francisco VA ... ,The study results may have implications on the treatment of ... it can be applied to humans. ,Insulin is ...
    ... plus progestin shows a 24 percent reduction in risk for ... than 10 years after menopause. ,The analysis, ... in the Kronos Early Estrogen Prevention Study (KEEPS), also showed ... 50 to 59 using hormone therapy. ,However, the ...
    ... be frowned upon. ,Dancing at all-night raves combined ... fluids// can produce enormous harm. Ecstasy interferes with the ... in deaths due to kidney or cardiovascular failure brought ... campaigners could warn. ,But a new study ...
    ... between secondhand smoke and an increased risk of Mycobacterium tuberculosis ... with TB, according to a study published in the April ... be a "cause of great concern considering the high prevalence ... Boon of KNCV Tuberculosis Foundation in the Netherlands said. ...
    Cached Medicine News:Health News:Acupuncture Points Way to Relief from Many Ailments 2Health News:Recovering Pranab Mukherjee Likely to Be Discharged Tomorrow 2Health News:Glucose Causes Death of Brain Cells in Rodents Following Hypoglycemic Coma 2Health News:Glucose Causes Death of Brain Cells in Rodents Following Hypoglycemic Coma 3Health News:Early Estrogen Therapy May Reduce Cardiovascular Risks 2Health News:Study Finds Link Between Secondhand Smoke and TB Infection in Children 2
    ... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    Medicine Products: